Tumor Prevention and Genetics by Hans-Jörg SennTumor Prevention and Genetics by Hans-Jörg Senn

Tumor Prevention and Genetics

EditorHans-Jörg Senn, Rudolf Morant

Paperback | October 8, 2012

Pricing and Purchase Info

$159.25 online 
$167.95 list price save 5%
Earn 796 plum® points

Prices and offers may vary in store


In stock online

Ships free on orders over $25

Not available in stores


This book presents a comprehensive update of the latest findings in oncogenetics. It also investigates the relevance of preclinical models with respect to clinical cancer prevention (primary and secondary) for major cancer types such as breast, skin, lung, prostate and colon cancer. All contributions have been written by internationally recognised experts in the field.
Title:Tumor Prevention and GeneticsFormat:PaperbackDimensions:273 pagesPublished:October 8, 2012Publisher:Springer Berlin HeidelbergLanguage:English

The following ISBNs are associated with this title:

ISBN - 10:3642628923

ISBN - 13:9783642628924

Look for similar items by category:


Table of Contents

From the contents: Genetic susceptibility, predicting risk and preventing cancer.- Novel approaches to identify low penetrance cancer susceptibility genes using mouse models.- Development of novel selective cell ablation in the mammary gland and brain to study cell-cell interactions and chemoprevention.- Mouse skin as a model for cancer chemoprevention by nonsteroidal anti-inflammatory drugs.- Preclinical models for chemoprevention of colon cancer.- New cancer biomarkers deriving from the NCI early detection research.- Tamoxifen's impact as a preventive agent in clinical practice.- Aromatase inhibitors in prevention.- HRT opposed to low dose Tamoxifen.- Is mammography screening for breast cancer really not justifiable?- How reliable is the evidence for screening mammography.- Breast cancer screening policies around the world.- Skin cancer chemoprevention.- Chemoprevention of non-melanoma skin cancer.- Chemoprevention of lung cancer.- Key issues in lung cancer chemoprevention trials of new agents.